NEUTRALIZING ANTIBODIES TO EBOLA VIRUS GLYCOPROTEIN AND THEIR USE
US Patent 11,976,109
Filed on 2020-07-01
Filed on 2020-07-01
NEUTRALIZING ANTIBODIES TO EBOLA VIRUS GLYCOPROTEIN AND THEIR USE
European Patent
18840136.8
Filed on 2018-12-31
18840136.8
Filed on 2018-12-31
USE OF GRAM NEGATIVE SPECIES TO TREAT ATOPIC DERMATITIS
US Application 16/848,587
Filed on 2020-04-14
Filed on 2020-04-14
Trispecific And/or Trivalent Binding Proteins For Prevention Or Treatment Of HIV Infection
Singapore
10202003467R
Filed on 2020-04-16
10202003467R
Filed on 2020-04-16
DEVELOPMENT OF DENGUE VIRUS VACCINE COMPONENTS
US Patent 11,332,722
Filed on 2020-06-25
Filed on 2020-06-25
CD47-targeted Therapies For The Treatment Of Infectious Disease
Turkey
17194591.8
Filed on 2017-10-03
17194591.8
Filed on 2017-10-03
CD47-targeted Therapies For The Treatment Of Infectious Disease
Sweden
17194591.8
Filed on 2017-10-03
17194591.8
Filed on 2017-10-03
CD47-targeted Therapies For The Treatment Of Infectious Disease
Norway
17194591.8
Filed on 2017-10-03
17194591.8
Filed on 2017-10-03